newdrugapprovals.org
FDA approves Mepsevii (vestronidase alfa-vjbk) for treatment for rare genetic enzyme disorder
FDA approves treatment for rare genetic enzyme disorder The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherite…